Tag: Pharmasynthez

Pharmsynthez is a Russian pharmaceutical company that specializes in producing and distributing innovative drugs. The company is able to work in three areas of drug manufacturing, laboratory research and development of new medicines, preparation of original active pharmaceutical ingredients and drugs, and launching products into markets. Such breadth is unusual for Russian pharmaceutical companies.
By constructing its own production facilities, Pharmsynthez will be able to replace contract manufacturing. This will significantly reduce its production costs, allowing it to saving upwards of $2 million per year.

Pharmasyntez signed an equipment supply contract with Bausch+Ströbel

The Pharmasyntez Group, one of three fastest developing Russian pharmaceutical companies, signed a contract with German equipment supplier Bausch+Ströbel.

Construction of a new pharmaceutical plant started in Usolye-Sibirskoye

An official ceremony marking the launch of construction was held at the site of future plant for active pharmaceutical substances and finished medicinal products of Pharmasyntez-Chemie in Usolye-Sibirskoye on June 15.

Pharmaceutical companies are actively investing in St. Petersburg SEZ

st petersburg sez
Since the beginning of 2018, the residents of St. Petersburg Special Economic Zone (SEZ) have invested 1.787 billion rubles in their projects. Over the same period of last year, the residents invested 1.537 billion rubles.

Construction of plant in Usolye-Sibirskoye will start before the end of 2018

Before the end of this year, Pharmasyntez JSC intends to start construction of a new pharmaceutical plant in Usolye-Sibirskoye Priority Development Area of Irkutsk region.

Pharmasyntez will construct a facility for production of amino acids

The acting Governor of Primorsky Krai met with President of Pharmasyntez Group, and General Director of East-Pharm JSC, the largest pharmaceutical plant in the region.

Pharmasyntez portfolio includes more than 30 drugs for treatment of TB infection

Pharmasyntez, a Russian company, views the manufacturing of TB drugs as a key area of its activities. Today, the products of Pharmasyntez hold 50% of the Russian market for TB drugs.

More than 12 billion rubles to be invested in the pharma industry of Irkutsk region

More than 12 billion rubles will be allocated, under the public-private partnership, to three projects aimed at developing the pharmaceutical industry in the Irkutsk region

Pharmasyntez completed another stage in modernization of its Irkutsk plant

The scheduled works on modernizing the granulation lines at the workshop No. 2 for solid dosage forms in the Irkutsk plant of Pharmasyntez were completed in January 2018. The workshop now has the n...

New Pharmasyntez plant will produce 30 types of hormonal drugs

About 30 types of hormonal drugs will be manufactured at the new plant in Tyumen region

Pharmasyntez opens a low-tonnage manufacturing shop in Irkutsk

JSC Pharmasyntez opened a new low-tonnage manufacturing shop in Irkutsk. This is an advanced high-tech production facility

Pharmasyntez-Retail will bring hypoglycemic drugs to the Russian market

Pharmasyntez, one of the leaders of Russian pharmaceutical industry enters the market with a new portfolio of hypoglycemic drugs

Pharmasyntez receives a land plot for a plant construction

Local authorities in Usolye-Sibirskoye leased a land plot of about 130 hectares to JSC Pharmasyntez

Pharmasyntez begins construction of a plant in the Tyumen region

The working equipment has rolled into the construction site in the Tyumen region, where a new import-substituting production facility is expected to be built within three years

Pharmasyntez plans to launch a drug substance plant in early 2018

According to the annual report of JSC Pharmasyntez (Irkutsk), in Q1 2018, the company plans to complete the construction and commissioning of a new plant for manufacturing the active pharmaceutical substances

Pharmasyntez will manufacture hormonal therapy medicines at its Tyumen site

The governor of the Tyumen region Vladimir Yakushev and Vikram Punia, the CEO of Pharmasyntez, announced strategic plans for the development of the company’s unit in Tyumen

Pharmasyntez will open new enterprises in Bratsk and Irkutsk

JSC Pharmasyntez plans to open two new pharmaceutical enterprises in the Irkutsk region this September